Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ABL Diagnostics S.A logo — Improving Diseases Management

ABL Diagnostics S.A

Improving Diseases Management

Founded 2015 France France 20 employees Venture round Information Technology

General Information

Company Name ABL Diagnostics S.A
Founded Year 2015
Location France France
Founders / Decision Makers
Team member
Employees 20
Industries Information Technology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with ABL Diagnostics S.A. To contact ABL Diagnostics S.A, visit abldiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ABL Diagnostics S.A compare?

A PDF of ABL Diagnostics S.A and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ABL Diagnostics S.A soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ABL Diagnostics S.A

ABL Diagnostics S.A is a France-based startup founded in 2015, dedicated to improving disease management through the development and commercialization of molecular biology diagnostic tests and DNA sequencing for infectious diseases. The company's flagship products, UltraGene® and DeepChek®, are the result of proprietary expertise and collaborations with renowned scientific teams. ABL Diagnostics is particularly focused on high-tech genotyping devices for chronic infectious diseases such as AIDS, viral hepatitis, tuberculosis, and the genotyping of SRAS-CoV-2 (Covid-19), as well as other viral and bacterial targets. In addition, it offers complementary products including sample collection kits, a specialized electronic clinical record, and medical devices for viral extraction, amplification, sequencing, and laboratory automation. The company, headquartered in Paris, Metz, and Marseille, generated a revenue of €6.27 million in 2021 and employs 25 professionals. With its recent Venture Round investment secured on 15 December 2005 led by S.R.I.W., ABL Diagnostics is well-positioned to continue its growth and innovation in the Information Technology sector. For more information, visit their website: [https://www.abldiagnostics.com/](https://www.abldiagnostics.com/)

Business keywords: Medical Data Technology, Diagnostics, Software Development, Infectious Diseases, HIV, SARS-CoV-2, Sequencing, Genotyping, EMR Systems, Healthcare Management, Virology, Next Generation Sequencing, Healthcare IT

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
S.R.I.W.
15 Dec 2005

ABL Diagnostics S.A Alternatives & Competitors

View All Alternatives
ABL Diagnostics S.A vs
SLIMS by Genohm, A part of Agilent
SLIMS by Genohm, A part of Agilent Switzerland

Manage your lab data in one place.

11 employees
Information Technology
ABL Diagnostics S.A vs
Fast Biotechnologies
Fast Biotechnologies Germany

Our mission is to save and improve lives by early diagnosis of life-threatening infections

2-10 employees
Biotechnology, Health Care
ABL Diagnostics S.A vs
echoBase
echoBase United States

Mobile iPad/iPhone interface for Physicians- Software developer echoBase delivers Resonate, a single...

Venture round
4 employees
Computing, Cyber Security
View all alternatives

FAQ About ABL Diagnostics S.A

Improving Diseases Management
ABL Diagnostics S.A was founded in 2015.
ABL Diagnostics S.A is headquartered in France.
ABL Diagnostics S.A operates in Information Technology. Its work centres on Medical Data Technology, Diagnostics, Software Development and Infectious Diseases.
ABL Diagnostics S.A has approximately 20 employees.
ABL Diagnostics S.A has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to ABL Diagnostics S.A include SLIMS by Genohm, A part of Agilent, Fast Biotechnologies, echoBase, Strand Life Sciences, INGRADIENT, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ABL Diagnostics S.A and SLIMS by Genohm, A part of Agilent are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ABL Diagnostics S.A, https://bouncewatch.com/company/abl-diagnostics-sa, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes